The FUS Foundation’s first newsletter of 2011 has been posted. This month’s issue spotlights exciting developments in an area of great potential for MR-guided focused ultrasound – pancreatic tumor treatment.
As you will read, clinicians in Europe recently treated patients with focused ultrasound to relieve pain associated with pancreatic tumors.
- At St. Mary’s Hospital in London, Wladyslaw Gedroyc, M.D. successfully treated an 89-year-old woman with a large, yet benign pancreatic tumor.
- At Sapienza University of Rome, Alessandro Napoli, M.D., Ph.D. and his colleagues achieved a major clinical milestone by treating the first patient with primary pancreatic cancer as part of a Phase 1 clinical trial.
In addition to the progress being made in the ablative uses of MR-guided focused ultrasound, this month’s featured researcher, Joo Ha Hwang, M.D., Ph.D. of the University of Washington, reports the technology holds great potential in mediating drug delivery to pancreatic tumors. Hwang and his colleagues are now conducting preclinical research. If results remain positive, they could launch clinical trials within a few years.
Click here to read the entire issue: